Atlas Trials

Efficacy and Safety of SBRT in Oligo-metastatic/Persistent/Recurrent Ovarian Cancer

Clinical trial NCT04593381 · COMPLETED

Trial details

NCT number
NCT04593381
Sponsor
Gemelli Molise Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Ovarian NeoplasmsRecurrent Ovarian CarcinomaOligometastatic Disease
Start date
2021-03-01
Primary completion
2023-12-31
Enrollment
376

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.